Hospital
QHG of South Carolina INC
QHG of South Carolina INC was paid $5.40M by Medicaid between Jan 2018 and May 2019, across 192 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 25% of everything it billed.
33Billing provider infoQHG OF SOUTH CAROLINA INC
FLORENCE, SC 29505
FLORENCE, SC 29505
33aNPI1235183328assigned 05/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.40M
24GClaims156,876
24DCodes billed192
24AFirst – last monthJan 2018 – May 2019
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#48 of 115
Median peer was paid$2.47M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 124,863 | $4.29M | |
| 2019 | 32,013 | $1.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 25% | 10,348 | 7,772 | $1.34M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 10,776 | 9,494 | $617K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.3% | 5,942 | 3,692 | $341K |
| 81025 | 6.0% | 3,801 | 3,469 | $324K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.7% | 2,823 | 2,622 | $307K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.3% | 2,182 | 2,093 | $232K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 3.2% | 123 | 112 | $172K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 2,257 | 1,686 | $157K |
| 82565 | 1.9% | 302 | 280 | $104K | |
| 59025 | Fetal non-stress test | 1.8% | 900 | 615 | $99K |
| 82947 | 1.6% | 1,828 | 895 | $88K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.4% | 5,891 | 5,211 | $78K |
180 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 734 | $58K |
| J2704 | Injection, propofol, 10 mg | 1.0% | 1,633 | $55K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 552 | $52K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 361 | $51K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 394 | $47K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,631 | $43K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 759 | $41K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 761 | $41K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 455 | $41K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,081 | $40K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,259 | $40K |
| 71250 | <1% | 211 | $40K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,119 | $36K |
| 81003 | <1% | 3,134 | $36K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,903 | $36K |
| 81001 | <1% | 2,453 | $33K | |
| 88304 | <1% | 172 | $33K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 506 | $33K |
| 72100 | <1% | 508 | $31K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 865 | $31K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,312 | $29K |
| 80053 | Comprehensive metabolic panel | <1% | 4,856 | $28K |
| 95813 | <1% | 138 | $28K | |
| 87070 | <1% | 251 | $27K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,892 | $24K |
| 74018 | <1% | 392 | $23K | |
| 73630 | <1% | 256 | $23K | |
| 73030 | <1% | 298 | $22K | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 42 | $22K |
| 73130 | <1% | 219 | $22K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,818 | $21K |
| 73610 | <1% | 193 | $21K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,531 | $20K |
| 73562 | <1% | 244 | $18K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 308 | $18K |
| 83021 | <1% | 229 | $17K | |
| 93971 | <1% | 88 | $16K | |
| 73110 | <1% | 156 | $15K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,268 | $15K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 35 | $13K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 43 | $13K |
| 94726 | <1% | 29 | $12K | |
| 80047 | <1% | 2,518 | $12K | |
| 87077 | <1% | 608 | $11K | |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 34 | $10K |
| 74022 | <1% | 491 | $10K | |
| 87807 | <1% | 985 | $10K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 315 | $10K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 178 | $9K |
| 72040 | <1% | 320 | $9K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 42 | $9K |
| 99285 | Emergency room visit (most serious) | <1% | 1,925 | $8K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 173 | $8K |
| G0378 | Hospital observation service, per hour | <1% | 655 | $8K |
| 73564 | <1% | 84 | $7K | |
| T5999 | Supply, not otherwise specified | <1% | 60 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,311 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,268 | $6K |
| 86850 | <1% | 269 | $6K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 97 | $5K |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 165 | $5K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 79 | $5K |
| 73502 | <1% | 107 | $5K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 379 | $5K |
| 93017 | <1% | 177 | $5K | |
| 85730 | <1% | 1,137 | $5K | |
| 86900 | <1% | 476 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 101 | $4K |
| 80081 | <1% | 317 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,088 | $4K |
| 87210 | <1% | 324 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 35 | $4K |
| 83690 | <1% | 1,727 | $4K | |
| 84484 | <1% | 2,665 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,221 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 65 | $3K |
| 83605 | <1% | 1,866 | $3K | |
| 83735 | <1% | 2,951 | $3K | |
| 87081 | <1% | 327 | $3K | |
| 95811 | <1% | 12 | $3K | |
| 84702 | <1% | 628 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 50 | $2K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 212 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 105 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $2K |
| 94760 | <1% | 157 | $2K | |
| 74019 | <1% | 49 | $2K | |
| 87186 | <1% | 553 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,159 | $1K |
| 73140 | <1% | 17 | $1K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 156 | $1K |
| 12001 | <1% | 12 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 272 | $1K |
| 85610 | <1% | 1,281 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,815 | $1K |
| 97161 | <1% | 139 | $1K | |
| 96367 | <1% | 116 | $960.90 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,161 | $895.12 |
| 84146 | <1% | 226 | $865.81 | |
| 84466 | <1% | 44 | $853.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 413 | $824.04 |
| 84145 | <1% | 603 | $803.74 | |
| 73080 | <1% | 13 | $716.46 | |
| 84439 | <1% | 695 | $689.53 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 336 | $637.78 |
| 85027 | <1% | 1,801 | $547.46 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 62 | $486.13 |
| 86592 | <1% | 108 | $467.83 | |
| 43235 | <1% | 71 | $451.86 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 575 | $444.82 |
| 80076 | <1% | 528 | $417.22 | |
| 96376 | <1% | 320 | $414.53 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 757 | $400.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,465 | $393.84 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,135 | $393.84 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 450 | $367.53 |
| 82607 | <1% | 194 | $355.69 | |
| 82550 | <1% | 939 | $288.81 | |
| 87205 | <1% | 201 | $248.10 | |
| 97116 | <1% | 64 | $225.94 | |
| A9270 | Non-covered item or service | <1% | 50 | $182.31 |
| 80061 | Lipid panel | <1% | 326 | $169.84 |
| 82570 | <1% | 13 | $162.32 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 395 | $158.84 |
| 36600 | <1% | 15 | $132.94 | |
| 94644 | <1% | 94 | $95.18 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 49 | $81.98 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 214 | $34.59 |
| 86140 | <1% | 459 | $33.76 | |
| 87040 | <1% | 691 | $24.55 | |
| 86901 | <1% | 477 | $19.75 | |
| 83540 | <1% | 78 | $17.03 | |
| 85379 | <1% | 428 | $13.63 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 17 | $12.28 |
| 84132 | <1% | 143 | $8.00 | |
| 85652 | <1% | 393 | $7.10 | |
| 84550 | <1% | 58 | $3.85 | |
| 85018 | <1% | 85 | $3.05 | |
| 83615 | <1% | 13 | $2.08 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 209 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 0% | 17 | $0.00 |
| 82248 | 0% | 975 | $0.00 | |
| 90715 | 0% | 71 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 114 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 280 | $0.00 |
| 82009 | 0% | 28 | $0.00 | |
| 50590 | 0% | 17 | $0.00 | |
| 96417 | 0% | 20 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 49 | $0.00 |
| 84156 | 0% | 13 | $0.00 | |
| 99152 | 0% | 30 | $0.00 | |
| 82805 | 0% | 14 | $0.00 | |
| 84100 | 0% | 19 | $0.00 | |
| 85014 | 0% | 60 | $0.00 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 13 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 17 | $0.00 |
| 83880 | 0% | 1,096 | $0.00 | |
| 82150 | 0% | 547 | $0.00 | |
| 94010 | 0% | 12 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 701 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 1,922 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 197 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,436 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 570 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 204 | $0.00 |
| C1769 | Guide wire | 0% | 59 | $0.00 |
| 82728 | 0% | 14 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 1,868 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 94 | $0.00 |
| 88342 | 0% | 28 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 74 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 17 | $0.00 |
| 74420 | 0% | 183 | $0.00 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 15 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 64 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 20 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 12 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 49 | $0.00 |
| 82746 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.